Loss on Drying (LOD) Testing for Active Pharmaceutical Ingredients: Principles, Methods, and Regulat

Loss on Drying (LOD) testing is a fundamental quality control procedure for active pharmaceutical ingredients (APIs), quantifying the volatile matter—including moisture and residual solvents—released when a drug substance is dried under precisely controlled conditions. This article provides a comprehensive technical overview of LOD testing for APIs, covering pharmacopeial methodologies (USP, Ph. Eur., ChP), sample handling, equipment, acceptance criteria, and regulatory applications in GMP batch release and stability programs. It is intended for pharmaceutical analysts, QA/QC professionals, and regulatory affairs specialists seeking reliable, standards-compliant drying loss evaluation of drug substances.

Technical Overview

Loss on Drying (LOD) is a gravimetric test that measures the percentage of mass lost by an active pharmaceutical ingredient when it is heated under specified conditions of temperature, pressure, and time. The weight loss typically corresponds to water and other volatile constituents, including low-boiling residual solvents from the final crystallization, washing, or drying steps of API manufacture. Because moisture content directly affects API potency correction, chemical stability, flowability, compactibility, and microbial risk, LOD is one of the most frequently performed release tests in pharmaceutical quality control.

The test is governed by harmonized or closely aligned pharmacopeial general chapters, including USP General Chapter <731> Loss on Drying, Ph. Eur. Method 2.2.32, JP Method 2.41, and ChP General Method 0831. Although the procedural details differ slightly between pharmacopeias, the core principle is identical: a pre-weighed sample is dried in a calibrated oven (or alternative drying apparatus) to constant weight or for a prescribed duration, cooled in a desiccator, re-weighed, and the percentage loss is calculated against the initial sample mass.

It is important to distinguish LOD from water determination by Karl Fischer (KF) titration. LOD is non-specific and captures all volatiles expelled under the drying conditions, whereas KF is specific to water. For APIs containing thermally labile components or higher-boiling residual solvents, the two methods can yield different results, and monograph specifications dictate which method applies. LOD testing is routinely performed within GMP-compliant laboratories (per ICH Q7) operated under ISO/IEC 17025-accredited quality systems or equivalent recognized standards.

Testing Samples

Powdered and Crystalline Drug Substances

The majority of APIs submitted for LOD testing are free-flowing powders or crystalline solids produced by final-step crystallization, micronization, or spray drying. These materials are sampled aseptically from containers using appropriate sampling plans (such as square root of container count plus one, per GMP conventions), homogenized, and protected from ambient humidity prior to analysis.

Hygroscopic and Moisture-Sensitive APIs

Hygroscopic drug substances, including many salts of weak bases, effervescent intermediates, and deliquescent compounds, require rapid sample transfer in low-humidity environments, sealed containers, and pre-dried weighing bottles. For such materials, the LOD value is often a critical quality attribute that defines packaging configuration and re-test period.

Heat-Sensitive and Oxidation-Prone Materials

APIs that degrade, sublime, or oxidize at elevated temperatures—such as certain vitamins, cephalosporin intermediates, and low-melting-point compounds—are tested under milder conditions, typically vacuum drying at 40–60 °C or drying over a desiccant at room temperature, as directed by the individual monograph.

Waxy, Viscous, or Liquid Matrices

Semi-solid or waxy drug substances can be spread as a thin film over the base of the weighing vessel, often with the aid of glass fiber filters or inert sand, to increase the evaporative surface area and ensure complete and reproducible volatile removal.

Process Intermediates and Development Batches

In addition to final drug substances, LOD testing is applied to wet cakes, dried granules, and intermediates during process development, scale-up, and drying-endpoint verification to support process validation under ICH Q8/Q11 principles.

Testing Items

Typical LOD test programs for active pharmaceutical ingredients include the following determinations:

• Total volatile content (moisture plus volatile residual solvents) expressed as percent weight loss (w/w)
• Compliance verification against the monograph or internal specification limit (commonly NMT 0.2%–1.0%, depending on the substance)
• Constant-weight verification, confirming that consecutive weighings differ by no more than the pharmacopeial tolerance (typically ≤0.5 mg per gram of sample after additional drying)
• Comparative LOD under alternative drying modes (atmospheric, vacuum, desiccant) for method development
• Repeatability and intermediate precision assessments during analytical method validation per ICH Q2
• Supporting data for stability protocols, packaging selection, and hold-time studies

Testing Methods

Constant-Temperature Drying Oven Method

The reference procedure uses a calibrated gravity-convection or forced-air drying oven. A glass weighing bottle with stopper is dried to constant weight, an accurately weighed sample (typically 1–2 g unless otherwise specified) is introduced, and the open bottle is dried at 105 °C for 3 hours or to constant weight, whichever is specified by the monograph. The bottle is stoppered, cooled to room temperature in a desiccator charged with anhydrous silica gel or phosphorus pentoxide, and re-weighed. Percent loss on drying is calculated as the mass difference divided by the original sample weight multiplied by 100.

Vacuum Drying Method

For thermolabile or solvent-retentive APIs, drying is performed under reduced pressure (commonly at 60 °C or below, at a pressure of a few millibars or specified mmHg) using phosphorus pentoxide or an equivalent desiccant in the vacuum oven. Lowering the operating pressure reduces the boiling points of water and residual solvents, enabling efficient volatile removal without thermal degradation.

Desiccant Drying (Room Temperature) Method

Where monographs specify drying over a desiccant without heat, the sample is held in a desiccator at ambient temperature until constant weight is achieved. This method suits APIs with very low melting points or those prone to solid-state transitions at elevated temperature.

Halogen Moisture Analyzer (Rapid LOD)

For high-throughput in-process control, a halogen-lamp thermogravimetric moisture analyzer provides an LOD-equivalent result in approximately 5–15 minutes. The instrument must be qualified and the method cross-validated against the pharmacopeial oven method, because heating profiles and atmosphere differ between the two techniques.

Thermogravimetric Analysis (TGA)

TGA measures mass loss as a continuous function of temperature and is invaluable during method development: the mass-loss curve helps select a drying temperature that removes volatiles completely while avoiding the onset of degradation or desolvation of stoichiometric hydrates. TGA data are frequently included in regulatory submissions to justify the chosen LOD conditions.

Method Validation and Instrument Qualification

Whichever technique is adopted, the laboratory performs oven temperature-mapping and balance calibration against certified reference masses, verifies desiccant activity, and documents accuracy, precision, and robustness in accordance with ICH Q2(R2) and data integrity expectations (ALCOA+ principles).

Applications

Loss on drying data for active pharmaceutical ingredients serve multiple critical purposes across the product lifecycle:

• Batch release testing: Demonstrating compliance with registered specifications before an API batch is released for formulation.
• Assay and content correction: Adjusting analytical results of API potency to an anhydrous or as-is basis, ensuring accurate dose delivery.
• Stability studies: Monitoring moisture trends under ICH Q1A(R2) storage conditions to assign re-test periods and shelf life.
• Process control and drying endpoint: Confirming that final drying operations (tray, fluid-bed, vacuum, or spray drying) have achieved the target residual volatile level.
• Regulatory submissions: Supporting Drug Master Files (DMFs/ASMFs), CTD Module 3.2.S specifications, and post-approval changes with scientifically justified acceptance criteria.
• Packaging and storage decisions: Defining moisture-barrier requirements, desiccant inclusion, and container-closure systems for moisture-sensitive APIs.
• Supplier and CDMO qualification: Comparing incoming material quality across vendors and sites within accredited third-party laboratories or internal GMP QC labs.

FAQ

What is the difference between loss on drying and water content by Karl Fischer titration?

Loss on drying is non-specific: it measures total mass lost under the drying conditions, which may include water, residual solvents, and other volatiles, and may even reflect slight decomposition in unstable compounds. Karl Fischer titration is a chemical method specific to water. Monographs select the appropriate technique based on the substance's volatility profile and thermal stability.

How is the drying temperature and duration selected?

Unless the monograph specifies otherwise, the default condition is 105 °C for 3 hours or to constant weight. For heat-sensitive APIs, lower temperatures with vacuum or desiccant drying are specified. Justification of drying conditions is typically supported by TGA or development data showing complete volatile removal without degradation.

What sample size is required for the test?

The pharmacopeial general chapters typically direct the use of approximately 1–2 g of the mixed sample, or the weight stated in the individual monograph, weighed accurately to 0.1 mg. Where a monograph specifies a weight, the amount taken should conform to pharmacopeial tolerances for prescribed quantities.

Why must samples be cooled in a desiccator before weighing?

Hot weighing bottles generate convection currents that destabilize the balance reading, and exposure of a hot sample to ambient air allows re-adsorption of atmospheric moisture. Cooling in a desiccator ensures reproducible, accurate weighing of the dried residue.

What does "constant weight" mean in practice?

Constant weight is achieved when the difference between two consecutive weighings after additional drying (commonly one further hour) does not exceed the tolerance stated in the applicable pharmacopeia—typically no more than 0.5 mg per gram of sample in USP practice. This criterion confirms that volatile removal is complete.

How are results reported and interpreted?

Results are reported as percentage loss on drying (%, w/w), usually compared against a specification such as "not more than 0.5%." Results exceeding the limit may indicate inadequate final drying, moisture uptake during packaging or transport, or storage in unsuitable conditions, and typically trigger investigation under the site's deviation management system.

Can a rapid moisture analyzer replace the pharmacopeial oven method?

A halogen or infrared moisture analyzer may be used for routine in-process checks, provided the method is validated to demonstrate equivalence to the compendial procedure for the specific API. Regulatory release testing generally relies on the pharmacopeial method unless an alternative method is justified and approved in the registered dossier.